Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley +1 more source
Extraordinarily High Brain Natriuretic Peptide (BNP) Level in a Case of Thyroid Storm. [PDF]
Ishii H, Ohashi K.
europepmc +1 more source
Acute effects of physiological increments of α-atrial natriuretic peptide in man
John C. Brown, Michael A. O'Flynn
openalex +1 more source
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer+25 more
wiley +1 more source
Hypertrichosis associated with the use of C-type natriuretic peptide analogue: a case report. [PDF]
Clinton JL+3 more
europepmc +1 more source
Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed+12 more
wiley +1 more source
Comparison of Natriuretic Peptide Levels in Sinus Rhythm and Atrial Fibrillation in Acute Heart Failure. [PDF]
Yoon M+10 more
europepmc +1 more source
Effectiveness of Atrial Natriuretic Peptide in the Treatment of Critically Ill Patients: A Systematic Review and Meta-Analysis. [PDF]
Odutola PO, Olarewaju A, Shah P.
europepmc +1 more source
The effect of different water temperatures on the release of the atrial natriuretic factor (ANF) during "head out water immersion (HOI)" [PDF]
Arendt, Rainer M.+5 more
core +1 more source
Brain natriuretic peptide is a biomarker of atrial fibrillation in hemodialysis patients. [PDF]
Yu L, Huang J, Li Y, Li H.
europepmc +1 more source